Post-tonsillectomy pain management in children: can we do better?

Area of Science:

• Pediatric Anesthesiology
• Pain Management
• Pharmacology

Background:

• Effective post-tonsillectomy pain management in children remains a challenge.
• Current analgesic options provide suboptimal pain relief.
• Investigating novel therapeutic strategies is crucial.

Purpose of the Study:

• To evaluate the efficacy of rofecoxib versus hydrocodone with acetaminophen for post-tonsillectomy pain relief in children.
• To compare active and passive pain scores and adverse effects between the two treatment groups.
• To assess pain control over a 72-hour period post-surgery.

Main Methods:

• Prospective, randomized, double-blind, active-controlled trial.
• 60 healthy children (ASA I-II) undergoing elective tonsillectomy were enrolled.
• Pain scores and side effects were assessed for 3 days postoperatively.

Main Results:

• Rofecoxib significantly reduced active pain scores at all time points after 6 hours compared to hydrocodone with acetaminophen.
• No significant differences in adverse effects were observed between the groups.
• The observed pain reduction with rofecoxib was not apparent in passive pain scores.

Conclusions:

• Rofecoxib demonstrates superior efficacy in reducing active post-tonsillectomy pain in children compared to hydrocodone with acetaminophen.
• The findings support the development of pediatric formulations of NSAIDs with enhanced COX-2 selectivity.
• Optimizing postsurgical pain relief in pediatric patients requires further investigation into targeted analgesic strategies.